NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
LogicBio Therapeutics Inc (F: 0IF)
0IF Technical Analysis
4
As on 15th Nov 2022 0IF STOCK Price closed @ 2.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 2.63 & Strong Sell for SHORT-TERM with Stoploss of 3.56 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0IFSTOCK Price
Open | 2.04 | Change | Price | % |
High | 2.04 | 1 Day | 0.00 | 0.00 |
Low | 2.04 | 1 Week | -0.04 | -1.92 |
Close | 2.04 | 1 Month | 1.75 | 603.45 |
Volume | N/A | 1 Year | -1.56 | -43.33 |
52 Week High 4.26 | 52 Week Low 0.28 |
F Germany Most Active Stocks
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
ENB | 47.60 | -0.92% |
TEF | 3.84 | -0.52% |
TEF | 3.84 | -0.52% |
WHL | 5150.00 | -0.44% |
WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
0IF Daily Charts |
0IF Intraday Charts |
Whats New @ Bazaartrend |
0IF Free Analysis |
|
0IF Important Levels Intraday
RESISTANCE | 2.04 |
RESISTANCE | 2.04 |
RESISTANCE | 2.04 |
RESISTANCE | 2.04 |
RESISTANCE | 2.04 |
RESISTANCE | 2.04 |
RESISTANCE | 2.04 |
RESISTANCE | 2.04 |
0IF Forecast December 2024
4th UP Forecast | 3.23 |
3rd UP Forecast | 2.85 |
2nd UP Forecast | 2.61 |
1st UP Forecast | 2.38 |
1st DOWN Forecast | 1.7 |
2nd DOWN Forecast | 1.47 |
3rd DOWN Forecast | 1.23 |
4th DOWN Forecast | 0.85 |
0IF Weekly Forecast
4th UP Forecast | 3.04 |
3rd UP Forecast | 2.72 |
2nd UP Forecast | 2.52 |
1st UP Forecast | 2.32 |
1st DOWN Forecast | 1.76 |
2nd DOWN Forecast | 1.56 |
3rd DOWN Forecast | 1.36 |
4th DOWN Forecast | 1.04 |
0IF Forecast2024
4th UP Forecast | 9.79 |
3rd UP Forecast | 7.3 |
2nd UP Forecast | 5.77 |
1st UP Forecast | 4.23 |
1st DOWN Forecast | -0.15 |
2nd DOWN Forecast | -1.69 |
3rd DOWN Forecast | -3.22 |
4th DOWN Forecast | -5.71 |
LogicBio Therapeutics Inc ( F Germany Symbol : 0IF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
0IF Other Details
Segment | EQ | |
Market Capital | 100866608.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
0IF Address
0IF Latest News
0IF Business Profile
LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. The company's lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. It has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as two additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop next-generation capsids for gene therapy and editing candidate LB-301 for the treatment of crigler-najjar syndrome. The company also has a strategic collaboration and option agreement with CANbridge Pharmaceuticals Inc. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Address: 65 Hayden Avenue, Lexington, MA, United States, 02421
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service